XBIOTECH INC. Deferred Tax Liabilities, Unrealized Currency Transaction Gains
XBIOTECH INC. (XBIT) had Deferred Tax Liabilities, Unrealized Currency Transaction Gains of $0 as of 2022-12-31, per its 10-K filed 2023-03-15.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains · last filed 2023-03-15
- 2022-12-31: Deferred Tax Liabilities, Unrealized Currency Transaction Gains $0.00.
- 2021-12-31: Deferred Tax Liabilities, Unrealized Currency Transaction Gains $14.00K.
- 2020-12-31: Deferred Tax Liabilities, Unrealized Currency Transaction Gains $108.00K.
- 2019-12-31: Deferred Tax Liabilities, Unrealized Currency Transaction Gains $0.00.
| Period end | Deferred Tax Liabilities, Unrealized Currency Transaction Gains |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-15 |
| 2021-12-31 | $14.00K 10-K · filed 2023-03-15 |
| 2020-12-31 | $108.00K 10-K · filed 2022-03-15 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-16 |
| 2018-12-31 | $0.00 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |